TMVR (Transcatheter Mitral Valve Replacement) and MitraClip

TMVR (Transcatheter Mitral Valve Replacement)** is a minimally invasive procedure aimed at treating severe mitral valve-related diseases, particularly in patients who are at high risk for traditional open-heart surgery. It involves the replacement of the diseased or dysfunctional mitral valve with a new valve delivered via catheterization, usually through the femoral vein. TMVR is intended for patients with significant mitral regurgitation or stenosis, providing an alternative to surgical options and allowing for greater access to patients who may not tolerate surgery well.

MitraClip is a specific device used in the treatment of mitral regurgitation. It is a less invasive option for patients with a leaky mitral valve, particularly those who are not candidates for surgery. The MitraClip is delivered via a catheter inserted typically through the femoral vein and maneuvers through the heart to clip the edges of the mitral valve leaflets together, reducing regurgitation and improving heart function. The procedure is performed under ultrasound guidance and is associated with shorter recovery times and reduced hospital stays compared to surgical interventions.

Both TMVR and MitraClip represent important advancements in cardiac care, offering less invasive alternatives to manage mitral valve disorders and improving outcomes for patients with limited surgical options.